TrialCancer medicine2023
Decitabine combined with RDHAP regimen in relapsed/refractory diffuse large B cell lymphoma.
Xiaoshuang Kong et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
9 papers cite it
this papertrialcites it
TrialCancer medicine2023
Xiaoshuang Kong et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.